Krauß SM, Holloway T, Weigert A, Bischof L, Backhaus D, Brauer D, Ussmann J, Franke G-N, Vučinić V, Platzbecker U, Schwind S, Jentzsch M, Metzeler KH. Next generation sequencing-based measurable residual disease detection predicts outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation. haematol [Internet]. 2020Sep.10 [cited 2026May30];. Available from: https://haematologica.org/article/view/14203